Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

被引：0
|
作者：
Lindner, Andrea K. [1 ]
Klatte, Tobias [2 ]
Comperat, Eva [3 ]
Heidegger, Isabel [1 ]
Pichler, Renate [1 ]
机构：
[1] Med Univ Innsbruck, Dept Urol, Innsbruck, Austria
[2] Royal Bournemouth & Christchurch Hosp, Dept Urol, Bournemouth, Dorset, England
[3] Sorbonne Univ, Hosp Tenon, Dept Pathol, Paris, France
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2019年 / 37卷 / 06期
关键词：
BACILLUS-CALMETTE-GUERIN; EXPRESSION; CARCINOMA;
D O I：
10.1016/j.urolonc.2019.02.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：343 / 345
页数：3
相关论文
共 50 条
  • [1] BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
    Lidagoster, Sarah
    Ben-David, Reuben
    De Leon, Benjamin
    Sfakianos, John P.
    CURRENT ONCOLOGY, 2024, 31 (02) : 1063 - 1078
  • [2] Non-muscle-invasive bladder cancer: a vision for the future
    Malmstrom, Per-Uno
    Agrawal, Sachin
    Blackberg, Mats
    Bostrom, Peter J.
    Malavaud, Bernard
    Zaak, Dirk
    Hermann, Gregers G.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (02) : 87 - 94
  • [3] Novel therapeutic targets and potential drugs for BCG incurable non-muscle-invasive bladder cancer
    Zhou, P.
    Hu, H.
    Hu, J.
    Wang, S.
    EUROPEAN UROLOGY, 2022, 81 : S110 - S110
  • [4] NOVEL THERAPEUTIC TARGETS AND POTENTIAL DRUGS FOR BCG INCURABLE NON-MUSCLE-INVASIVE BLADDER CANCER
    Zhou Peng
    Hu Henglong
    Wang Shaogang
    JOURNAL OF UROLOGY, 2022, 207 (05): : E934 - E934
  • [5] What is the optimal BCG dose in non-muscle-invasive bladder cancer?
    Witjes, J. Alfred
    EUROPEAN UROLOGY, 2007, 52 (05) : 1300 - 1302
  • [6] Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer
    Cooley, Lauren Folgosa
    McLaughlin, Kimberly A.
    Meeks, Joshua J.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (01) : 35 - +
  • [7] Navigating the Challenges of BCG-Unresponsive Non-muscle-invasive Bladder Cancer: Insights and Future Directions
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2024, 86 (06) : 528 - 530
  • [8] Treatment options in non-muscle-invasive bladder cancer after BCG failure
    Brooks, Nathan A.
    O'Donnell, Michael A.
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 312 - 319
  • [9] Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
    Moussa, Mohamad
    Papatsoris, Athanasios G.
    Dellis, Athanasios
    Abou Chakra, Mohamed
    Saad, Wajih
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (11) : 965 - 983
  • [10] Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG
    Barlow, LaMont J.
    Seager, Catherine M.
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (01) : 108 - 111
12345